Improve balance using wearable technology
- Trial ID
- NCT05680597
- Official Title
- Balance Tele-rehabilitation With Wearable Technology for Older Adults With Parkinson's Disease
- Goal
- Improve balance using wearable technology
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Oregon Health and Science University
- Study Type
- INTERVENTIONAL
- Enrollment
- 80 participants
- Conditions
- Parkinson Disease
- Interventions
- Balance Tele-Rehabilitation Agility Boot Camp (ABC)
Plain-Language Summary
The trial is testing whether a remote, wearable-guided balance and agility program can improve balance and walking and reduce fall risk in older adults with Parkinson's. Participants do the Agility Boot Camp (ABC) exercises via tele-rehabilitation about three times a week for four weeks while wearable sensors track sway, steps, and movement to give objective feedback and measure changes; because it is an exercise intervention it does not change how levodopa works, and participants are asked to keep their Parkinson's medications stable during the study. They are enrolling people 55 to 85 years old with idiopathic, levodopa-responsive Parkinson's in Hoehn and Yahr stages I to III who can follow directions and participate in exercise, are not frequent fallers, have no major medical or cognitive barriers, and can stand and walk without an assistive device.
Locations
- Oregon Health Science University, Portland, Oregon, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Balance Tele-Rehabilitation Agility Boot Camp (ABC). The trial is testing whether a remote, wearable-guided balance and agility program can improve balance and walking and reduce fall risk in older adults with Parkinson's. Participants do the Agility Boot Camp (ABC) exercises via tele-rehabilitation about three times a week for four weeks while wearable sensors track sway, steps, and movement to give objective feedback and measure changes; because it is an exercise intervention it does not change how levodopa works, and participants are asked to keep their Parkinson's medications stable during the study. They are enrolling people 55 to 85 years old with idiopathic, levodopa-responsive Parkinson's in Hoehn and Yahr stages I to III who can follow directions and participate in exercise, are not frequent fallers, have no major medical or cognitive barriers, and can stand and walk without an assistive device.
- Who can participate?
- Participants must be between 55 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 4 years and 8 months.